These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24046248)

  • 1. [Tricyclic antidepressant plasma levels in depression: a practical guide].
    Vis R; Hassink JJ; Vinkers CH
    Tijdschr Psychiatr; 2013; 55(9):695-705. PubMed ID: 24046248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tricyclic antidepressant concentrations to determine individual response.
    Morin A; Stoukides CA
    Ann Pharmacother; 1993; 27(7-8):896-7. PubMed ID: 8364275
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring tricyclic antidepressant plasma levels.
    Sato TL; Madakasira S
    Am Fam Physician; 1984 May; 29(5):199-202. PubMed ID: 6731239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of tricyclic antidepressant plasma levels.
    Silverman JJ; Brennan P; Friedel RO
    Psychosomatics; 1979 Nov; 20(11):736-40, 745-6. PubMed ID: 523591
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic monitoring of plasma concentrations of tricyclic antidepressants. Perspective of the clinical laboratory.
    Jatlow P
    Arch Pathol Lab Med; 1980 Jul; 104(7):341-4. PubMed ID: 6893119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma.
    Mercolini L; Mandrioli R; Finizio G; Boncompagni G; Raggi MA
    J Sep Sci; 2010 Jan; 33(1):23-30. PubMed ID: 20091716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of tricyclic antidepressant levels in an outpatient clinic.
    Biggs JT; Chang SS; Sherman WR; Holland WH
    J Nerv Ment Dis; 1976 Jan; 162(1):46-51. PubMed ID: 1245849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of assays in tricyclic antidepressant therapy.
    Clower CG
    Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.
    Preskorn SH
    J Clin Psychiatry; 1989 Jul; 50 Suppl():34-42; discussion 43-6. PubMed ID: 2661550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of depression: benefits and limits of blood levels of tricyclic antidepressants].
    Baumann P
    Schweiz Med Wochenschr; 1981 Feb; 111(7):228-39. PubMed ID: 7013064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monitoring of tricyclic antidepressants: quality-control considerations.
    Orsulak PJ; Gerson B
    Ther Drug Monit; 1980; 2(3):233-42. PubMed ID: 7222178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
    Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of plasma level monitoring of tricyclic antidepressants in clinical practice.
    Asberg M; Sjöqvist F
    Commun Psychopharmacol; 1978; 2(5):381-91. PubMed ID: 738018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.